IGF-1 (Insulin-like Growth Factor-1)
The Somatotropic Axis and IGF-1 Production
Insulin-like Growth Factor-1 (IGF-1), historically known as Somatomedin C, is the primary mediator of the effects of growth hormone (GH). The physiological cascade begins in the hypothalamus, which secretes Growth Hormone-Releasing Hormone (GHRH). GHRH stimulates the anterior pituitary to release GH into systemic circulation. Upon reaching the liver, GH binds to the Growth Hormone Receptor (GHR), initiating a JAK2/STAT5b intracellular signaling cascade. This transcriptional activation leads to the hepatic synthesis and secretion of IGF-1. While the liver is the primary endocrine source of circulating IGF-1, it is also produced locally in various tissues (including skeletal muscle and bone) where it acts in an autocrine or paracrine manner.
IGF Binding Proteins (IGFBPs)
In systemic circulation, over 98% of IGF-1 is bound to one of six IGF Binding Proteins (IGFBP-1 through IGFBP-6). The most abundant of these is IGFBP-3, which forms a ternary complex with IGF-1 and the Acid-Labile Subunit (ALS). This binding significantly extends the half-life of IGF-1 in the bloodstream (from minutes for free IGF-1 to over 12 hours for the ternary complex) and regulates its bioavailability by preventing it from indiscriminately activating receptors. For IGF-1 to exert its biological effects, it must dissociate from these binding proteins, a process often mediated by specific proteases in the target tissue microenvironment.
Receptor Activation and Intracellular Signaling
Free IGF-1 exerts its biological effects primarily by binding to the Type 1 IGF Receptor (IGF-1R), a receptor tyrosine kinase structurally homologous to the insulin receptor. Upon ligand binding, the IGF-1R undergoes a conformational change leading to autophosphorylation of tyrosine residues in its intracellular domain. This creates docking sites for adapter proteins, most notably Insulin Receptor Substrate-1 (IRS-1) and Shc.
The recruitment of IRS-1 leads to the activation of Phosphoinositide 3-kinase (PI3K), which converts PIP2 to PIP3, subsequently activating Akt (Protein Kinase B). The PI3K/Akt pathway is the primary driver of IGF-1's metabolic and anti-apoptotic effects. Akt phosphorylates and inhibits downstream targets like FOXO transcription factors and GSK-3beta, while activating mTORC1. The activation of mTORC1 is critical for skeletal muscle hypertrophy, as it upregulates ribosomal biogenesis and translation initiation, driving robust protein synthesis.
Concurrently, the recruitment of Shc activates the Ras/Raf/MEK/ERK (MAPK) pathway. This signaling cascade translocates to the nucleus to regulate gene expression, driving cellular proliferation, differentiation, and survival. The dual activation of the PI3K/Akt and MAPK pathways makes IGF-1 a potent mitogen and survival factor across numerous cell types.
Cross-Reactivity with Insulin Receptors
Because IGF-1 shares approximately 50% amino acid sequence homology with insulin, it can bind to the insulin receptor, albeit with roughly 100-fold lower affinity than insulin itself. Conversely, insulin can bind to the IGF-1R at high physiological or pharmacological concentrations. This structural similarity explains why exogenous administration of IGF-1 (such as the pharmaceutical Mecasermin) can induce hypoglycemia and improve insulin sensitivity in patients with severe insulin resistance or Type 2 Diabetes.
Engineered Analogs: LONG® R³ IGF-I
In both clinical research and cell culture applications, native IGF-1 is often limited by its rapid sequestration by IGFBPs. To circumvent this, recombinant analogs have been engineered. LONG® R³ IGF-I is a prime example. It features a substitution of an arginine (Arg) for a glutamic acid (Glu) at position three, combined with a 13-amino acid N-terminal extension peptide. These structural modifications result in a greater than 1000-fold reduced affinity for IGFBPs. Consequently, LONG® R³ IGF-I remains free and biologically active, making it up to 200 times more potent and twice as stable in cell culture environments compared to standard insulin or native IGF-1.
Do IGF-1 supplements work? +
Can you get IGF-1 over the counter? +
Can I take IGF-1 being diabetic? +
What supplements increase IGF-1 levels? +
What are the risks of taking IGF-1? +
Can IGF-1 cause joint pain? +
Can you take IGF-1 and testosterone together? +
Is Deer Antler Velvet a good source of IGF-1? +
Why is IGF-1 banned in sports? +
What is LONG R3 IGF-1? +
How does Vitamin D affect IGF-1? +
What is Mecasermin? +
Does fasting increase IGF-1? +
How does IGF-1 differ from Growth Hormone? +
Can IGF-1 make you taller? +
Everything About IGF-1 (Insulin-like Growth Factor-1) Article
The Ultimate Guide to IGF-1 (Insulin-like Growth Factor-1)
Insulin-like Growth Factor-1 (IGF-1) is one of the most powerful, misunderstood, and highly sought-after hormones in the realms of endocrinology, anti-aging, and sports performance. Produced primarily in the liver in response to Growth Hormone (GH), IGF-1 is the actual metabolic workhorse that drives muscle growth, bone density, and cellular repair.
However, the gap between pharmaceutical, injectable IGF-1 and the over-the-counter (OTC) supplements sold online is massive. This comprehensive guide explores the biochemistry of IGF-1, the truth about OTC supplements, the medical applications of synthetic versions, and how to naturally optimize your body's own IGF-1 production.
What is IGF-1 and How Does it Work?
IGF-1, historically referred to as Somatomedin C, is a polypeptide hormone consisting of 70 amino acids. It is an integral part of the somatotropic axis. When the pituitary gland releases Growth Hormone (GH) into the bloodstream, it travels to the liver. The liver responds by synthesizing and secreting IGF-1.
Once in the bloodstream, IGF-1 binds to the IGF-1 Receptor (IGF-1R) on the surface of cells throughout the body. This binding triggers a cascade of intracellular events, most notably the activation of the PI3K/Akt/mTOR pathway and the Ras/MAPK pathway.
- The mTOR Pathway: This is the body's primary driver of protein synthesis. By activating mTOR, IGF-1 tells skeletal muscle cells to grow, repair, and multiply. - The MAPK Pathway: This pathway drives cellular proliferation and differentiation, essential for tissue repair and overall growth.
Furthermore, IGF-1 shares a striking structural similarity to insulin. Because of this, it can bind to insulin receptors and help shuttle glucose out of the blood and into muscle cells, improving insulin sensitivity and nutrient partitioning.
The Disconnect: Pharmaceutical vs. Over-the-Counter
When discussing IGF-1, it is critical to separate pharmaceutical drugs from dietary supplements.
Pharmaceutical IGF-1 (Mecasermin) Mecasermin (sold under brand names like Increlex) is a synthetic, recombinant version of human IGF-1. It is administered via subcutaneous injection and is strictly regulated. Doctors prescribe it primarily for children who suffer from severe primary IGF-1 deficiency or GH gene deletions—conditions where the body simply cannot produce enough IGF-1 to support normal growth.
Because it is injected directly into the tissue, Mecasermin is highly bioavailable. It effectively bypasses the digestive system and enters systemic circulation to exert its powerful effects.
Over-the-Counter IGF-1 Supplements Walk into a supplement store or search online, and you will find products claiming to contain IGF-1, often derived from Deer Antler Velvet. Bodybuilders and athletes have historically flocked to these products hoping for accelerated recovery and muscle growth.
Here is the biochemical reality: IGF-1 is a fragile peptide hormone. If you consume it orally, the harsh acidic environment of the stomach and the proteolytic enzymes in the digestive tract will rapidly break it down into individual amino acids before it can ever reach your bloodstream.
Some manufacturers attempt to bypass this by using sublingual sprays or liposomal delivery systems. While liposomes can offer some protection, the molecular weight of IGF-1 makes sublingual absorption highly inefficient. Consequently, the vast majority of OTC IGF-1 supplements do not significantly elevate systemic IGF-1 levels.
Engineered Analogs: The Science of LONG® R³ IGF-I
In the scientific community, researchers often use modified versions of IGF-1 for cell culture and laboratory studies. One of the most famous is LONG® R³ IGF-I.
In the human body, over 98% of IGF-1 is bound to IGF Binding Proteins (IGFBPs). When bound, IGF-1 is inactive. LONG® R³ IGF-I was engineered by substituting the amino acid arginine for glutamic acid at position three, and adding a 13-amino acid extension. This brilliant piece of biochemical engineering reduces the peptide's affinity for IGFBPs by over 1000-fold.
As a result, LONG® R³ IGF-I is up to 200 times more potent than standard insulin or native IGF-1 in cell cultures because it remains "free" and active. While LONG® R³ IGF-I is strictly a research chemical and not approved for human use, its existence highlights how binding proteins regulate natural IGF-1 in the body.
Natural Ways to Boost Endogenous IGF-1
If OTC supplements are largely ineffective and pharmaceutical injections are illegal for athletes (and dangerous without medical supervision), how can you optimize IGF-1?
1. Vitamin D Supplementation Recent clinical meta-analyses have revealed a fascinating link between Vitamin D and IGF-1. A comprehensive review published in Ageing Research Reviews analyzed multiple randomized controlled trials and found that Vitamin D supplementation significantly increases circulating IGF-1 levels. Interestingly, the data suggested that moderate doses (≤1000 IU/day) and shorter intervention periods (≤12 weeks) were highly effective at raising IGF-1.
2. High-Intensity Exercise Resistance training and high-intensity interval training (HIIT) stimulate the acute release of Growth Hormone, which subsequently signals the liver to produce more IGF-1. Furthermore, intense muscle contraction stimulates the local, autocrine production of a specific splice variant of IGF-1 known as Mechano Growth Factor (MGF), which acts directly on the exercised muscle to trigger repair.
3. Adequate Protein and Caloric Intake The liver's ability to produce IGF-1 in response to GH is highly dependent on nutritional status. Fasting, severe caloric restriction, and protein deficiency cause the liver to become resistant to GH, plummeting IGF-1 levels. Consuming adequate high-quality protein and maintaining a caloric surplus or maintenance level is essential for optimal IGF-1 production.
The Dark Side: Risks, Side Effects, and WADA Bans
More IGF-1 is not always better. The hormone is a potent mitogen, meaning it tells cells to divide and multiply. While this is great for muscle cells, it is catastrophic if applied to cancer cells.
Cancer Risk Epidemiological studies have consistently linked high circulating levels of IGF-1 with an increased risk of several cancers, including breast, prostate, colon, and lung cancer. IGF-1 does not necessarily cause the initial genetic mutation, but it provides a powerful growth signal that can cause existing, undetected tumors to grow rapidly.
Hypoglycemia Because IGF-1 mimics insulin, exogenous administration can cause severe drops in blood sugar (hypoglycemia). Symptoms include sweating, dizziness, confusion, and in severe cases, loss of consciousness.
Acromegaly and Joint Pain Long-term abuse of exogenous IGF-1 or GH can lead to acromegaly—the abnormal growth of the hands, feet, jaw, and internal organs. Users also frequently report severe joint pain, carpal tunnel syndrome, and fluid retention.
The WADA Ban Due to its potent performance-enhancing effects and significant health risks, the World Anti-Doping Agency (WADA) has banned all forms of IGF-1, including synthetic injections and OTC supplements like deer antler velvet. Athletes caught using these substances face severe sanctions and bans from competition.
Conclusion
IGF-1 is a master regulator of human growth, metabolism, and cellular repair. While pharmaceutical interventions are life-changing for children with growth deficiencies, the OTC supplement market is fraught with ineffective products due to the biological limitations of oral peptide absorption. For the average individual looking to improve body composition and recovery, focusing on natural optimization through resistance training, adequate nutrition, and Vitamin D supplementation remains the safest and most scientifically sound approach.